HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

dichlorotetrakis(dimethyl sulfoxide)ruthenium II (trans-Ru)

RN given refers to parent cpd without isomeric designation,
Also Known As:
trans-Ru; RuCl2(DMSO)4; cis-RuCl2(DMSO)4; cis-dichlorotetrakis(dimethyl sulfoxide)ruthenium II; dichlorotetrakis(dimethyl sulfoxide)ruthenium II, (S)-(OC-6-22)-isomer; trans-RuCl2(DMSO)4
Networked: 15 relevant articles (2 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Espreafico, Enilza M: 2 articles (10/2013 - 04/2008)
2. Gomes, Anderson J: 2 articles (10/2013 - 04/2008)
3. Tfouni, Elia: 2 articles (10/2013 - 04/2008)
4. Alessio, E: 2 articles (12/2000 - 09/2000)
5. Bergamo, A: 2 articles (12/2000 - 09/2000)
6. Gava, B: 2 articles (12/2000 - 09/2000)
7. Iengo, E: 2 articles (12/2000 - 09/2000)
8. Sava, G: 2 articles (12/2000 - 09/2000)
9. Sorc, A: 2 articles (12/2000 - 09/2000)
10. Zorzet, S: 2 articles (12/2000 - 09/2000)

Related Diseases

1. Carcinoma (Carcinomatosis)
2. Neoplasms (Cancer)
3. Adenocarcinoma
4. Breast Neoplasms (Breast Cancer)
5. Melanoma (Melanoma, Malignant)

Related Drugs and Biologics

1. Nitric Oxide (Nitrogen Monoxide)
2. imidazolium- bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(III) (NAMI-A)
3. Plastics
4. Ruthenium
5. Mercaptopurine (6 Mercaptopurine)
6. 2,2'-Dipyridyl (2,2 Bipyridine)
7. Thiazoles
8. Solutions
9. Sodium
10. Plasminogen Activators (Plasminogen Activator)